These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30278461)

  • 21. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway.
    Zhang CY; Yu MS; Li X; Zhang Z; Han CR; Yan B
    Tumour Biol; 2017 Jun; 39(6):1010428317701311. PubMed ID: 28635399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity.
    Sun L; Li Y; Yang B
    Biochem Biophys Res Commun; 2016 Sep; 478(1):323-329. PubMed ID: 27166155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters.
    Záveský L; Jandáková E; Weinberger V; Minář L; Kohoutová M; Slanař O
    Cancer Biomark; 2024; 40(1):61-78. PubMed ID: 38277283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of ERBB family mRNA expression in breast carcinomas.
    Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics analysis of potential prognostic biomarkers among Krüppel-like transcription Factors (KLFs) in breast cancer.
    Cheng L; Shi L; Dai H
    Cancer Biomark; 2019; 26(4):411-420. PubMed ID: 31640084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. linc00673 (ERRLR01) is a prognostic indicator of overall survival in breast cancer.
    Abdul-Rahman U; Győrffy B; Adams BD
    Transcription; 2018; 9(1):17-29. PubMed ID: 28795861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer.
    Li X; Gou J; Li H; Yang X
    Sci Rep; 2020 Oct; 10(1):17739. PubMed ID: 33082469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer.
    Huang X; Li X; Xie X; Ye F; Chen B; Song C; Tang H; Xie X
    Breast; 2016 Dec; 30():39-46. PubMed ID: 27598996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.
    Bieche I; Parfait B; Le Doussal V; Olivi M; Rio MC; Lidereau R; Vidaud M
    Cancer Res; 2001 Feb; 61(4):1652-8. PubMed ID: 11245479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer.
    Yang F; Liu YH; Dong SY; Ma RM; Bhandari A; Zhang XH; Wang OC
    Biochem Biophys Res Commun; 2016 Feb; 470(3):479-483. PubMed ID: 26820525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
    Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
    Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.
    Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X
    PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Status of Long Non-Coding RNAs in Human Breast Cancer.
    Cerk S; Schwarzenbacher D; Adiprasito JB; Stotz M; Hutterer GC; Gerger A; Ling H; Calin GA; Pichler M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
    Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
    Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between Mutation and Expression of
    Kim JY; Park K; Jung HH; Lee E; Cho EY; Lee KH; Bae SY; Lee SK; Kim SW; Lee JE; Nam SJ; Ahn JS; Im YH; Park YH
    Cancer Res Treat; 2016 Oct; 48(4):1338-1350. PubMed ID: 26910472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
    Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
    BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis.
    Cui X; Jing X; Long C; Tian J; Zhu J
    Oncotarget; 2017 Mar; 8(12):19049-19056. PubMed ID: 28157702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis of the prognostic value of glutathione S-transferases Mu family members in breast cancer.
    Gohari N; Abbasi E; Akrami H
    Cell Biol Int; 2024 Sep; 48(9):1313-1325. PubMed ID: 38922769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
    Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
    Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.
    Gao Y; Lu X
    Tumour Biol; 2016 Feb; 37(2):1461-9. PubMed ID: 26662307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.